Pandemic

Page 31 of 43

Beating COVID will require a 5-part strategy—including mandatory boosters and a drug we don’t have yet
Commentary

Beating COVID will require a 5-part strategy—including mandatory boosters and a drug we don’t have yet

By Mark Dybul and Serhat Gümrükçü
November 22, 2021
Then-CEO of Unilever Paul Polman, attends a talk where Prince William, Duke of Cambridge introduces new workplace mental health initiatives at Unilever House on March 1, 2018 in London, England.
Newsletters

The world has changed but many boards ‘have not moved on’

By David Meyer and Alan Murray
November 19, 2021
Rosalind Brewer, Executive Vice President and President of Walmart East speaks during the Martin Luther King, Jr. Memorial Dream Gala at Hilton Hotel on October 15, 2011 in Washington, DC.
Newsletters

What the CEOs of Walgreens, Hilton and Progressive think about the Great Resignation

By David Meyer and Alan Murray
November 18, 2021
Simon Segars, CEO of ARM; Katie Koch, co-head, Fundamental Equity, at Goldman Sachs Asset Management; Barbara Humpton, president and CEO of Siemens; and Matt Heimer of FORTUNE
Newsletters

Resiliency, climate and China: Lessons from Day 2 of the Fortune CEO Initiative

By David Meyer and Alan Murray
November 17, 2021
Albert Bourla, chief operating officer and chief executive officer of Pfizer Inc., testifies during a Senate Finance Committee hearing on drug pricing on Capitol Hill in Washington, D.C., U.S., on Tuesday, Feb. 26, 2019.
Newsletters

Albert Bourla explains how Pfizer moved so quickly to create its COVID-19 vaccine

By David Meyer and Alan Murray
November 16, 2021
Why the physical and economic pain of ‘long COVID’ will probably well outlast the pandemic
Health

Why the physical and economic pain of ‘long COVID’ will probably well outlast the pandemic

By Jason Gale and Bloomberg
November 16, 2021
Roll of American dollars banknotes on the beige background
Newsletters

Why treat capital gains differently when the world is awash in capital?

By David Meyer and Alan Murray
November 15, 2021
A man walks through the empty main room in the OVO Hydro building on day thirteen of the COP26 at SECC on November 12, 2021 in Glasgow, Scotland.
Newsletters

After COP26, businesses can expect things to start changing very quickly

By Katherine Dunn and David Meyer
November 12, 2021
A health worker administers the third dose of the AstraZeneca vaccine to a senior citizen as part of the vaccination campaign on November 8, 2021 in Cuenca, Ecuador.
Health

AstraZeneca shifts away from nonprofit model for its COVID-19 vaccine, except when selling to poor countries

By
November 12, 2021
Larry Culp, chief executive officer of General Electric Co., speaks during a Bloomberg Television interview in New York, U.S., on Tuesday, Nov. 9, 2021.
Newsletters

As GE splits, Larry Culp has no regrets

By David Meyer and Alan Murray
November 11, 2021
Lessons from day 2 of Brainstorm AI: How strategic A.I. choices pay off
Newsletters

Lessons from day 2 of Brainstorm AI: How strategic A.I. choices pay off

By David Meyer and Alan Murray
November 10, 2021
Brainstorm AI provides lessons in the successful adoption of artificial intelligence
Newsletters

Brainstorm AI provides lessons in the successful adoption of artificial intelligence

By David Meyer and Alan Murray
November 9, 2021
Denmark's Prime Minister Mette Frederiksen waits to make a national statement on the second day of the COP26 UN Climate Summit in Glasgow on November 2, 2021.
Health

Denmark ditched its COVID rules 2 months ago. Now cases are up—and restrictions are coming back

By
November 8, 2021
John Doerr, Partner at Kleiner Perkins Caufield & Byers, a venture capital firm speaks during the TechCrunch Disrupt conference in New York, on Monday, May 24, 2010.
Newsletters

VC pioneer John Doerr extends his management tools to address the climate crisis

By David Meyer and Alan Murray
November 8, 2021
In this photo illustration a multiple exposure image shows a Pfizer logo displayed on a smartphone with stock market percentages in the background.
Health

Pfizer says its COVID pill cuts rates of death and hospitalization by 89%, sending shares skyward

By
November 5, 2021

Most Popular